1
|
Kayton A, Timoney P, Vargo L and Perez JA:
A review of oxygen physiology and appropriate management of oxygen
levels in premature neonates. Adv Neonatal Care. 18:98–104. 2018.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Vogel ER, Britt RD Jr, Trinidad MC, Faksh
A, Martin RJ, MacFarlane PM, Pabelick CM and Prakash YS: Perinatal
oxygen in the developing lung. Can J Physiol Pharmacol. 93:119–127.
2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Perrone S, Bracciali C, Di Virgilio N and
Buonocore G: Oxygen use in neonatal care: A two-edged sword. Front
Pediatr. 9:1432017.
|
4
|
Jobe AH: Mechanisms of lung injury and
bronchopulmonary dysplasia. Am J Perinatol. 33:1076–1078. 2016.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Thekkeveedu Kalikkot R, Guaman MC and
Shivanna B: Bronchopulmonary dysplasia: A review of pathogenesis
and pathophysiology. Respir Med. 132:170–177. 2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Coalson JJ: Pathology of bronchopulmonary
dysplasia. Semin Perinatol. 30:179–184. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sheppard D: Epithelial-mesenchymal
interactions in fibrosis and repair. Transforming growth factor-β
activation by epithelial cells and fibroblasts. Ann Am Thorac Soc.
1 Suppl 12:S21–S23. 2015. View Article : Google Scholar
|
8
|
McGowan S: Understanding the developmental
pathways pulmonary fibroblasts may follow during alveolar
regeneration. Cell Tissue Res. 367:707–719. 2017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Murray MJ: The role of netrins and their
receptors in epithelial mesenchymal plasticity during development.
Cells Tissues Organs. 203:71–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Hayes D Jr, Feola DJ, Murphy BS, Shook LA
and Ballard HO: Pathogenesis of bronchopulmonary dysplasia.
Respiration. 79:425–436. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Porzionato A, Sfriso MM, Mazzatenta A,
Macchi V, De Caro R and Di Giulio C: Effects of hyperoxic exposure
on signal transduction pathways in the lung. Respir Physiol
Neurobiol. 209:106–114. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rubinfeld H and Seger R: The ERK cascade:
A prototype of MAPK signaling. Mol Biotechnol. 31:151–174. 2005.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Bélanger LF, Roy S, Tremblay M, Brott B,
Steff AM, Mourad W, Hugo P, Erikson R and Charron J: Mek2 is
dispensable for mouse growth and development. Mol Cell Biol.
23:4778–4787. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Jakkula M, Le Cras TD, Gebb S, Hirth KP,
Tuder RM, Voelkel NF and Abman SH: Inhibition of angiogenesis
decreases alveolarization in the developing rat lung. Am J Physiol
Lung Cell Mol Physiol. 279:L600–L607. 2000. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ashcroft T, Simpson JM and Timbrell V:
Simple method of estimating severity of pulmonary fibrosis on a
numerical scale. J Clin Pathol. 41:467–470. 1988. View Article : Google Scholar : PubMed/NCBI
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Coalson JJ: Experimental models of
bronchopulmonary dysplasia. Biol Neonate. 1 Suppl 71:S35–S38. 1997.
View Article : Google Scholar
|
18
|
Baraldi E and Filippone M: Chronic lung
disease after premature birth. N Engl J Med. 357:1946–1955. 2007.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Chen Y, Whitney PL and Frank L:
Comparative responses of premature versus full-term newborn rats to
prolonged hyperoxia. Pediatr Res. 35:233–237. 1994. View Article : Google Scholar : PubMed/NCBI
|
20
|
Cox AM, Gao Y, Perl AT, Tepper RS and
Ahlfeld SK: Cumulative effects of neonatal hyperoxia on murine
alveolar structure and function. Pediatr Pulmonol. 52:616–624.
2017. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hussain N, Wu F, Christian C and Kresch
MJ: Hyperoxia inhibits fetal rat lung fibroblast proliferation and
expression of procollagens. Am J Physiol. 273:L726–L732.
1997.PubMed/NCBI
|
22
|
Silva DM, Nardiello C, Pozarska A and
Morty RE: Recent advances in the mechanisms of lung alveolarization
and the pathogenesis of bronchopulmonary dysplasia. Am J Physiol
Lung Cell Mol Physiol. 309:L1239–L1272. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Porzionato A, Zaramella P, Macchi V,
Grisafi D, Salmaso R, Baraldi M, Fornaro E, Tassone E, Masola V,
Onisto M, et al: Fluoxetine may worsen hyperoxia-induced lung
damage in neonatal rats. Histol Histopathol. 27:1599–1610.
2012.PubMed/NCBI
|
24
|
Porzionato A, Zaramella P, Macchi V,
Sarasin G, Di Giulio C, Rigon A, Grisafi D, Dedja A, Chiandetti L
and De Caro R: Cyclosporine and hyperoxia-induced lung damage in
neonatal rats. Respir Physiol Neurobiol. 187:41–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Grisafi D, Pozzobon M, Dedja A, Vanzo V,
Tomanin R, Porzionato A, Macchi V, Salmaso R, Scarpa M, Cozzi E, et
al: Human amniotic fluid stem cells protect rat lungs exposed to
moderate hyperoxia. Pediatr Pulmonol. 48:1070–1080. 2013.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Grisafi D, Tassone E, Dedja A, Oselladore
B, Masola V, Guzzardo V, Porzionato A, Salmaso R, Albertin G,
Artusi C, et al: L-citrulline prevents alveolar and vascular
derangement in a rat model of moderate hyperoxia-induced lung
injury. Lung. 190:419–430. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Jiang JS, Lang YD, Chou HC, Shih CM, Wu
MY, Chen CM and Wang LF: Activation of the renin-angiotensin system
in hyperoxia-induced lung fibrosis in neonatal rats. Neonatology.
101:47–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Li Z, Choo-Wing R, Sun H, Sureshbabu A,
Sakurai R, Rehan VK and Bhandari V: A potential role of the JNK
pathway in hyperoxia-induced cell death, myofibroblast
transdifferentiation and TGF-β1-mediated injury in the developing
murine lung. BMC Cell Biol. 12:542011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lang YD, Hung CL, Wu TY, Wang LF and Chen
CM: The renin-angiotensin system mediates hyperoxia-induced
collagen production in human lung fibroblasts. Free Radic Biol Med.
49:88–95. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Li LF, Liao SK, Huang CC, Hung MJ and
Quinn DA: Serine/threonine kinase-protein kinase B and extracellar
signal-regulated kinase regulate ventilator-induced pulmonary
fibrosis after bleomycin-induced acute lung injury: A prospective,
controlled animal experiment. Crit Care. 12:R1032008. View Article : Google Scholar : PubMed/NCBI
|
31
|
Aoidi R, Maltais A and Charron J:
Functional redundancy of the kinases MEK1 and MEK2: Rescue of the
Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold
effect. Sci Signal. 9:ra92016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Boucherat O, Landry-Truchon K, Aoidi R,
Houde N, Nadeau V, Charron J and Jeannotte L: Lung development
requires an active ERK/MAPK pathway in the lung mesenchyme. Dev
Dyn. 246:72–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Boucherat O, Nadeau V, Bérubé-Simard FA,
Charron J and Jeannotte L: Crucial requirement of ERK/MAPK
signaling in respiratory tract development. Development.
142:38012015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Jiang HD and Guan HS: MS80, a novel
sulfated oligosaccharide, inhibites pulmonary fibrosis by targeting
TGF-beta1 both in vitro and in vivo. Acta Pharmacol Sin.
30:973–979. 2009. View Article : Google Scholar : PubMed/NCBI
|
35
|
Caraci F, Gili E, Calafiore M, Failla M,
La Rosa C, Crimi N, Sortino MA, Nicoletti F, Copani A and Vancheri
C: TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK
activation in the transition of human lung fibroblasts into
myofibroblasts. Pharmacol Res. 57:274–282. 2008. View Article : Google Scholar : PubMed/NCBI
|
36
|
Asano K, Shikama Y, Shoji N, Hirano K,
Suzaki H and Nakajima H: Tiotropium bromide inhibits TGF-β-induced
MMP production from lung fibroblasts by interfering with Smad and
MAPK pathways in vitro. Int J Chron Obstruct Pulmon Dis. 5:277–286.
2010. View Article : Google Scholar : PubMed/NCBI
|
37
|
Fang LP, Lin Q, Tang CS and Liu XM:
Hydrogen sulfide suppresses migration, proliferation and
myofibroblast transdifferentiation of human lung fibroblasts. Pulm
Pharmacol Ther. 22:554–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Lin Q, Fang LP, Zhou WW and Liu XM:
Rosiglitazone inhibits migration, proliferation, and phenotypic
differentiation in cultured human lung fibroblasts. Exp Lung Res.
36:120–128. 2010. View Article : Google Scholar : PubMed/NCBI
|